Contract research news in brief
September 24, 2012Research and Development AMRI, Celerion, Covance, GNS Healthcare, INC Research, Knopp Biosciences, PPD, Vitalea Bioscience
A round-up of recent developments in the contract research sector, including updates from Covance/GNS, AMRI, Celerion, PPD, INC Research and …
EC publishes trio of revised GMP Guide sections
September 24, 2012Manufacturing and Production EC, EU, GMP, ICH
The European Commission has published two revised chapters in its Good Manufacturing Practice (GMP) Guide, along with an update of …
Eliquis receives nod in AF
September 24, 2012Sales and Marketing BMS, CHMP, Eliquis, Pfizer, Pradaxa, Xarelto
Bristol-Myers Squibb and Pfizer have received a boost with the CHMP’s recommendation that their co-marketed oral anticoagulant Eliquis should gain …
CMO market on the up says new study
September 24, 2012Manufacturing and Production API, CMO, manufacturing
The global contract manufacturing market is expected to reach a value of nearly $48 billion this year on the back …
Amgen names Ray Jordan senior VP Corporate Affairs
September 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, J&J, JJ, Ray Jordan
Amgen has announced the appointment of ex-J&J comms leader Ray Jordan to the new position of senior vice president, Corporate …
New possibility for Lilly erectile drug
September 24, 2012Sales and Marketing CHMP, Cialis, ED, hyperplasia, lilly
Eli Lilly’s erectile disfunction (ED) brand Cialis has been recommended to treat benign prostatic hyperplasia (BPH) in Europe. If the …
Pharma creates non-profit R&D organisation
September 21, 2012Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma
Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …
China sees fresh wave of drug price cuts
September 21, 2012Manufacturing and Production, Sales and Marketing China, Lunt, NDRC, ageing
China has unveiled yet another round of price cuts to prescription medicines. The price cuts cover more than 200 formulations …
Transgene appoints Nathalie Adda as chief medical officer
September 21, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Nathalie Adda, Transgene
Transgene has announced the appointment of Dr Nathalie Adda as chief medical officer. Responsible for medical and regulatory affairs of …
Merz Pharma slammed by PMCPA
September 21, 2012Medical Communications, Sales and Marketing ABPI, Merz Pharma, PMCPA
Merz Pharma UK has been rapped over the knuckles for three of the most serious breaches it is possible to …
Almirall’s COPD drug launched in Europe
September 20, 2012Sales and Marketing Advair, Almirall, Eklira, Genuair, Seretide, Spiriva
Almirall has launched COPD treatment Eklira in Denmark following approval from the European Commission. Phase III trials demonstrated that Eklira …
Teva announces appointment of Prof Itzhak Krinsky
September 20, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Itzhak Krinsky, Teva
Teva has announced the appointment of Professor Itzhak Krinsky as chairman of Teva Japan and Teva South Korea and head …
Sanofi cleared in sales row
September 20, 2012Medical Communications, Sales and Marketing ABPI, CDF, Jevtana, PMCPA, Sanofi
Sanofi has been cleared of any wrongdoing after allegations that it had broken multiple clauses in the ABPI Code of …
Boehringer submits new lung cancer drug
September 20, 2012Research and Development, Sales and Marketing Boehringer, NSCLC, Roche, Tarceva, afatinib
Boehringer Ingelheim has filed its new lung cancer drug with the EMA. Afatinib is the latest targeted therapy for lung …
Sandra Peterson joins J&J’s executive committee
September 20, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Sandra Peterson
Sandra Peterson will join Johnson & Johnson on 1 December as Group Worldwide chairman and member of the company’s executive …
Afinitor’s new UK indication launched
September 20, 2012Sales and Marketing Afinitor, CHMP, Novartis, breast cancer
Novartis’ cancer drug Afinitor has been made available in the UK for patients with the most common form of advanced …
RSA announces new Board members
September 20, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nick Stephens, RSA executive search
Life sciences executive search and interim management specialists RSA has announced the appointment of Nick Stephens as executive chairman, John …
Silence Therapeutics appoints chief medical adviser
September 19, 2012Business Services, Research and Development, Sales and Marketing Michael Khan, Silence Therapeutics
Silence Therapeutics has announced the appointment of Michael Khan to its board of directors as chief medical adviser. Dr Khan …
J&J sets up life science centres
September 19, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, R&D, innovation
Johnson & Johnson is to set up what it calls regional innovation centres in a bid to speed up the …
Steven Gillis to join Shire Board of directors
September 19, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Steven Gillis
Shire has announced that Dr Steven Gillis will join the Board of directors in October this year. On joining the …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
